Activated Charcoal Oral Suspension — FDA Drug Shortage

To Be Discontinued — Padagis US LLC

The FDA lists a drug shortage record for Activated Charcoal Oral Suspension (oral suspension) from Padagis US LLC with status To Be Discontinued. The shortage was first posted on May 15, 2026.

Shortage details

Status
To Be Discontinued
Company
Padagis US LLC
Package NDC
0574-0521-25
Dosage Form
Oral Suspension
Presentation
Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25)
Initial Posting
May 15, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.